IndraLab

Statements


| 2

reach
"Hepatocyte deletion of USP15 suppresses liver steatosis, inflammation, and fibrosis in mouse models of NASH."

reach
"Researchers discovered that The expression of the deubiquitinating enzyme USP15 is upregulated in the livers of HFD-fed mice and in liver biopsy tissues from patients with NAFLD or NASH, whereas hepatocyte deletion of USP15 suppresses hepatic steatosis, inflammation, and fibrosis in a mouse model of NASH (133)."